GB999237A - Quinoline derivatives - Google Patents

Quinoline derivatives

Info

Publication number
GB999237A
GB999237A GB2488763A GB2488763A GB999237A GB 999237 A GB999237 A GB 999237A GB 2488763 A GB2488763 A GB 2488763A GB 2488763 A GB2488763 A GB 2488763A GB 999237 A GB999237 A GB 999237A
Authority
GB
United Kingdom
Prior art keywords
group
formula
compounds
compound
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2488763A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc SA
Original Assignee
Rhone Poulenc SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc SA filed Critical Rhone Poulenc SA
Publication of GB999237A publication Critical patent/GB999237A/en
Expired legal-status Critical Current

Links

Abstract

The invention comprises compounds of the formulae <FORM:0999237/C2/1> wherein A represents a divalent straight or branched chain aliphatic hydrocarbon group containing 2 to 6 carbon atoms, R and R1 represent, the same or different, a hydrogen atom or an alkyl group containing up to 4 carbon atoms and B represents a single bond or a group -A1-NH-, in which A1 has the same significance as A and is attached to the nitrogen atom of the ethylenediamine group, and non-toxic acid addition salts thereof and the preparation thereof by reacting a 7-chloroquinoline of the formula <FORM:0999237/C2/2> with a compound of the formula <FORM:0999237/C2/3> where (a) Y represent a halogen atom or phenoxy group, one of V and W represents a group -ANH-, the group A being attached to a nitrogen atom of the ethylenediamine group, and the other represents the symbol B in the formula I; (b) Y represents the group <FORM:0999237/C2/4> , wherein X represents the acid residue of a reactive ester, Z represents a hydrogen atom, an alkanoyl group of up to 4 carbon atoms or a benzoyl group, V represents a single bond and W represents B1, i e a single bond or the group -A1-NZ-; and, if necessary, removing from the resultant product the group Z The compounds are also prepared by reacting two molecules of a 7-chloroquinoline of the formula II wherein Y represents a halogen atom or phenoxy group with one molecule of a compound of the formula <FORM:0999237/C2/5> and where B represents a group identical with that represented by -HN-A-, by reacting two molecules of a 7-chloroquinoline of the formula <FORM:0999237/C2/6> with one molecule of a compound of the formula <FORM:0999237/C2/7> Compounds of the formula III may be made by condensing equimolecular proportions of a compound of the formula II and a compound of the formula IV <FORM:0999237/C2/8> wherein Y, V and W have the significance set out under the heading (a) above. Where V represents a single bond and W represents the group -A-NZ-, compounds of the formula III may be made by condensing equimolecular proportions of compounds of the formulae V and VI. 1,10 - Diamino - 4,7 - diazadecane is prepared by catalytic reduction of 1,8-dicyano-3,6-diazooctane which is made by condensation of acrylonitrile with ethylene diamine. N - Ethyl - N,N - bis(2 - aminoethyl)amine is made by dephthalimidation of N-ethyl-N,N-bis (2-phthalimido-ethyl)amine which is made by the condensation of N-ethyl-N,N-bis(2-chloroethyl) amine with potassium phthalimide. Pharmaceutical compositions for oral, rectal and parenteral administration, which have antimalarial, amoebicidic and anthelmintic properties and which may take the form of tablets, pills, dispersible powders, granules, emulsions, solutions, suspensions, syrups and elixirs comprise compounds of the general formula I and addition salts thereof.
GB2488763A 1962-06-22 1963-06-21 Quinoline derivatives Expired GB999237A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR901653 1962-06-22

Publications (1)

Publication Number Publication Date
GB999237A true GB999237A (en) 1965-07-21

Family

ID=8781651

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2488763A Expired GB999237A (en) 1962-06-22 1963-06-21 Quinoline derivatives

Country Status (7)

Country Link
AT (1) AT240364B (en)
CH (1) CH424781A (en)
DE (1) DE1296635B (en)
DK (2) DK104735C (en)
ES (1) ES289291A1 (en)
GB (1) GB999237A (en)
LU (1) LU43783A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001044198A1 (en) * 1999-12-17 2001-06-21 G.O.T. Gesellschaft Für Therapieoptimierung Und Targeting Entwicklungs Mbh Amphiphilic quinolylpolyamines as transfer agents for biologically active macromolecules
WO2007097450A1 (en) * 2006-02-27 2007-08-30 Nagoya City University Compound with antimalarial activity and antimalarial drug containing the same as active ingredient
JP2014513101A (en) * 2011-04-29 2014-05-29 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom, and uses thereof
US10221140B2 (en) 2014-08-08 2019-03-05 The Trustees Of The University Of Pennsylvania Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1052356A (en) * 1952-03-12 1954-01-25 Rhone Poulenc Sa New quinoline derivatives and their preparation process

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001044198A1 (en) * 1999-12-17 2001-06-21 G.O.T. Gesellschaft Für Therapieoptimierung Und Targeting Entwicklungs Mbh Amphiphilic quinolylpolyamines as transfer agents for biologically active macromolecules
WO2007097450A1 (en) * 2006-02-27 2007-08-30 Nagoya City University Compound with antimalarial activity and antimalarial drug containing the same as active ingredient
JP2014513101A (en) * 2011-04-29 2014-05-29 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom, and uses thereof
AU2012249646B2 (en) * 2011-04-29 2017-06-08 The Trustees Of The University Of Pennsylvania Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
US20170166530A1 (en) * 2011-04-29 2017-06-15 The Trustees Of The University Of Pennsylvania Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
US10047052B2 (en) 2011-04-29 2018-08-14 The Trustees Of The University Of Pennsylvania Bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
US11591298B2 (en) 2011-04-29 2023-02-28 The Trustees Of The University Of Pennsylvania Bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
US10221140B2 (en) 2014-08-08 2019-03-05 The Trustees Of The University Of Pennsylvania Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy
US11001558B2 (en) 2014-08-08 2021-05-11 The Trustees Of The University Of Pennsylvania Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy
US11639335B2 (en) 2014-08-08 2023-05-02 The Trustees Of The University Of Pennsylvania Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy

Also Published As

Publication number Publication date
AT240364B (en) 1965-05-25
ES289291A1 (en) 1963-12-16
DK104735C (en) 1966-06-27
CH424781A (en) 1966-11-30
LU43783A1 (en) 1963-07-22
DE1296635B (en) 1969-09-18
DK107807C (en) 1967-07-10

Similar Documents

Publication Publication Date Title
GB1395764A (en) Cytidines and related compounds
GB1114155A (en) Guanidino derivatives
GB921547A (en) Derivatives of 2-hydroxy-5,9-dimethyl-6,7-benzomorphane, their salts, and process for their production
GB999237A (en) Quinoline derivatives
GB1318645A (en) 1,2,4-triazines
KR840008023A (en) Method for preparing chromone- and thiochromone-substituted 1,4-dihydropyridine derivatives
GB964143A (en) Substituted quinolines
GB1341809A (en) Phenanthridine derivatives
GB823191A (en) New phenthiazine derivatives and processes for their preparation
GB1047245A (en)
GB1047061A (en) Polymers and a process for the preparation thereof
GB1086735A (en) New alkyleneimines and process for their manufacture
GB1082964A (en) New substituted imidazolines and their preparation and use
GB973903A (en) Substituted bis-[(quinolylamino)alkyl]piperazines
GB959993A (en) Camphor derivatives
ES273823A1 (en) Phenothiazine derivatives
GB921474A (en) New phenthiazine derivatives
GB990092A (en) Novel indole derivatives and a process for the manufacture thereof
GB1017986A (en) Iminodibenzyl derivatives
GB1356747A (en)
GB1326925A (en) 9-amino-alkyl-1,10-dihydro-9,10-etheno-anthracenes and process for their manufacture
ES286809A1 (en) Novel benzoxazepine derivatives and a process for the manufacture thereof
GB823338A (en) Diquaternary salts of aminoalkyl piperidines
GB1005893A (en) Quinoline derivatives
GB1071815A (en) Phenothiazine derivatives